Search Results 701-710 of 18971 for hepatitis

1. A Study to Evaluate Acalabrutinib With or Without Obinutuzumab to Treat Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients - Mayo Clinic

   those who are hepatitis B surface antigen positive or hepatitis B PCR positive and those who are hepatitis C PCR positive will be excluded - History of ...

2. Liver cancer - Doctors and departments - Mayo Clinic

   ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease. Show more areas of focus for ...

3. Cladribine (oral route) - Mayo Clinic

   Other Medical Problems · Cancer or; Hepatitis infection, chronic, active or · Cancer, history of or; Heart disease—Use with caution. · Hepatitis B or C or ...

4. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Participation eligibility · Patients with a positive hepatitis B core antibody but with negative hepatitis B DNA may participate, but must have hepatitis ...

5. Gemifloxacin (oral route) - Side effects & dosage - Mayo Clinic

   Liver disease (including hepatitis) or; Mental illness, history of or; Myocardial ischemia (reduced blood supply in the heart) or; Seizures (epilepsy), or ...

6. Cohort of Patients With Fatty Liver Disease - Mayo Clinic

   History of hepatitis B or C virus (HBV, HCV) infections;; History of alcoholic liver disease or alcohol abuse;; Autoimmune hepatitis;; Alpha-1-antitrypsin ...

7. Primary biliary cholangitis - Diagnosis and treatment - Mayo Clinic

   Do you have a history of hepatitis or other liver disease? Does anyone in your family have liver disease? How much alcohol do you drink? What medicines are ...

8. Ofatumumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Hepatitis B, active—Should not be used in patients with this condition. Hepatitis B, history of or; Liver disease, history of—Use with caution. May make ...

9. GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   * Hepatitis C virus (HCV): If hepatitis C antibody result is positive, patient will need to have a negative result for hepatitis C ribonucleic acid (RNA).

10. Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia - Mayo Clinic

    Hepatitis B carrier status history of hepatitis B virus (HBV) or positive serology; a patient is considered as HBV carrier or to have (had) HBV infection in ...